JP2012501318A5 - - Google Patents

Download PDF

Info

Publication number
JP2012501318A5
JP2012501318A5 JP2011524451A JP2011524451A JP2012501318A5 JP 2012501318 A5 JP2012501318 A5 JP 2012501318A5 JP 2011524451 A JP2011524451 A JP 2011524451A JP 2011524451 A JP2011524451 A JP 2011524451A JP 2012501318 A5 JP2012501318 A5 JP 2012501318A5
Authority
JP
Japan
Prior art keywords
binding moiety
eoc
ovarian cancer
protein
binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011524451A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012501318A (ja
Filing date
Publication date
Priority claimed from GBGB0815846.1A external-priority patent/GB0815846D0/en
Application filed filed Critical
Publication of JP2012501318A publication Critical patent/JP2012501318A/ja
Publication of JP2012501318A5 publication Critical patent/JP2012501318A5/ja
Pending legal-status Critical Current

Links

JP2011524451A 2008-09-01 2009-09-01 上皮性卵巣癌の診断又は予後診断方法 Pending JP2012501318A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0815846.1 2008-09-01
GBGB0815846.1A GB0815846D0 (en) 2008-09-01 2008-09-01 diagnosis, prognosis and imaging of disease
PCT/GB2009/002098 WO2010023458A1 (en) 2008-09-01 2009-09-01 Method of diagnosing or prognosing epithelial ovarian cancer

Publications (2)

Publication Number Publication Date
JP2012501318A JP2012501318A (ja) 2012-01-19
JP2012501318A5 true JP2012501318A5 (enExample) 2012-10-18

Family

ID=39866018

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011524451A Pending JP2012501318A (ja) 2008-09-01 2009-09-01 上皮性卵巣癌の診断又は予後診断方法

Country Status (7)

Country Link
US (4) US20110217238A1 (enExample)
EP (1) EP2329042B1 (enExample)
JP (1) JP2012501318A (enExample)
CN (1) CN102186994A (enExample)
ES (1) ES2605254T3 (enExample)
GB (1) GB0815846D0 (enExample)
WO (1) WO2010023458A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2442919T3 (es) 2007-03-27 2014-02-14 Immunovia Ab Firma/marcadores de proteínas para la detección de adenocarcinoma
GB0910620D0 (en) * 2009-06-19 2009-08-05 Immunovia Ab Agents and uses thereof
WO2013013117A1 (en) 2011-07-20 2013-01-24 Mikroscan Technologies, Inc. Network-based pathology system with desktop slide scanner
US20150284783A1 (en) * 2012-05-21 2015-10-08 Agena Bioscience, Inc. Methods and compositions for analyzing nucleic acid
GB201319878D0 (en) * 2013-11-11 2013-12-25 Immunovia Ab Method, Array and use thereof
US10119901B2 (en) 2013-11-15 2018-11-06 Mikroscan Technologies, Inc. Geological scanner
US10162166B2 (en) 2014-10-28 2018-12-25 Mikroscan Technologies, Inc. Microdissection viewing system
US20170097355A1 (en) * 2015-10-06 2017-04-06 University Of Washington Biomarkers and methods to distinguish ovarian cancer from benign tumors
CN108085392A (zh) * 2018-01-09 2018-05-29 山大生殖研发中心有限公司 上皮性卵巢癌的生物标志物及其用途
GB202010970D0 (en) 2020-07-16 2020-09-02 Immunovia Ab Methods, arrays and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070237770A1 (en) * 2001-11-30 2007-10-11 Albert Lai Novel compositions and methods in cancer
EP2003196A3 (en) * 2003-06-09 2009-01-07 The Regents of the University of Michigan Compositions and methods for treating and diagnosing cancer
WO2005002417A2 (en) * 2003-06-20 2005-01-13 Avalon Pharmaceuticals, Inc. Cancer -linked gene aas target for chemotherapy
MXPA05014220A (es) * 2003-07-02 2006-03-09 Novartis Ag Genes regulados en cancer ovarico como objetivos de pronostico y terapeuticos.
EP1806413A1 (en) * 2006-01-06 2007-07-11 Oligene GmbH An in-vitro-method and means for determination of different tumor types and predicting success of surgical procedures in ovarian cancer

Similar Documents

Publication Publication Date Title
JP2012501318A5 (enExample)
NZ600828A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
JP2008249727A5 (enExample)
JP2013521763A5 (enExample)
NZ619883A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
KR20080114689A (ko) 증가된 ｂｃｌ-2에 의한 암의 발견
JP2010513901A5 (enExample)
BR112012019542A2 (pt) "método para avaliar o estado renal em um indivíduo, medição de um ou mais biomarcadores, e, kit"
NZ603492A (en) Humanized anti-factor d antibodies and uses thereof
WO2008134526A3 (en) Glycoprotein profiling of bladder cancer
CA2792163A1 (en) Biomarkers of osteoarthritis
JP2011516038A5 (enExample)
MY162697A (en) Methods, devices and kits for detecting or monitoring acute kidney injury
JP2010207229A5 (enExample)
US10724097B2 (en) Methods and compositions for diagnosis and management of diabetes and metabolic syndrome
JP2011517937A5 (enExample)
JP2013531784A5 (enExample)
RU2022108606A (ru) Антитела к фактору ix padua
KR101478826B1 (ko) 신규한 대장암 진단용 마커 및 이를 이용한 대장암 진단 키트
ES2861440T5 (en) Use of nucleosome-transcription factor complexes for cancer detection
ES2551713T3 (es) Procedimientos para el diagnóstico o pronóstico de cáncer colorrectal
CN103487588B (zh) Galectin-4蛋白在制备巨大肝癌术后预后评估试剂盒中的应用
JP2009539370A5 (enExample)
JP2011516037A5 (enExample)
CN107110848B (zh) 以脱氧羟腐胺缩赖氨酸合酶基因作为指标使用的动脉硬化及癌的检测方法